Document is current
Any future updates will be listed below
-
Authors
Young, Christina B. https://orcid.org/0000-0001-9535-2137
Johns, Emily
Kennedy, Gabriel
Belloy, Michael E.
Insel, Philip S.
Greicius, Michael D.
Sperling, Reisa A.
Johnson, Keith A.
Poston, Kathleen L.
Mormino, Elizabeth C.
,
,
-
Funding
Funding for this research was provided by:
National Institute of Aging (K99AG071837, K99AG075238, P30AG066515, K01AG051718, P01AG036694, P50AG005134, U24AG074855)
National Institute of Neurological Disorders and Stroke (R01NS115114)
Alzheimer's Association (AARFD-21-849349, AARF-20-683984)
- License Information
-
More Information
Article History
Received: 12 October 2022
Accepted: 14 December 2022
First Online: 4 January 2023
Declarations
:
: All A4 participants completed written informed consent before participation. All ADNI participants provided written informed consent in compliance with local IRBs.
: Not applicable.
: KLP received consulting fees from CuraSen Therapeutics Inc. ECM is a paid consultant for Roche, Genentech, and Eli Lilly. All other authors have no disclosures relevant to the manuscript.
